Dyve Biosciences to Present at the 32nd Annual Oppenheimer Healthcare Conference
CAMARILLO, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Dyve Biosciences, Inc. (“Dyve”), a clinical-stage biotech company applying its proprietary transdermal...
CAMARILLO, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Dyve Biosciences, Inc. (“Dyve”), a clinical-stage biotech company applying its proprietary transdermal...
SAN DIEGO, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical...
Morgan Tapped to Lead Company’s Mission to Disrupt Drug Discovery and Precision Medicine TYSONS, Va.--(BUSINESS WIRE)--Zephyr AI, Inc. (“Zephyr AI”),...
Key appointment will guide the Company’s strategic growth initiatives NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American:...
Live Call/Webcast on Wednesday, February 23, 2022 at 5 pm ET TORONTO & DALLAS--(BUSINESS WIRE)--$PINK.V #AI--Perimeter Medical Imaging AI, Inc....
Open-label, randomized, controlled study will evaluate BT-001, a prescription digital therapeutic (PDT) delivering cognitive behavioral therapy to address behavioral root...
The partnership enables participation in North Carolina’s health information exchange (HIE) for thousands of SimplePractice customer practices serving clients using...
Vancouver, British Columbia--(Newsfile Corp. - February 16, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"...
STOCKHOLM, SWEDEN / ACCESSWIRE / February 16, 2022 / Promore Pharma (STO:PROMO)(FRA:8T0)October to DecemberNet sales amounted to MSEK 0 (0)Net...
STOCKHOLM, SWEDEN / ACCESSWIRE / February 16, 2022 / Promore Pharma (STO:PROMO)(FRA:8T0)STOCKHOLM, 16 February 2022 - Promore Pharma AB, a...
STOCKHOLM, SWEDEN / ACCESSWIRE / February 16, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group (publ.) hereby announces that our partner Zafe...
Long-term agreement includes a series of investments to acquire new equipment and adapt the present ROVI drug product fill-finish facilities...
GOTHENBURG, SWEDEN / ACCESSWIRE / February 16, 2022 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)IRLAB Therapeutics AB (publ) will publish the year-end report...
GENEVA, SWITZERLAND / ACCESSWIRE / February 16, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) ("Relief"), a biopharmaceutical company seeking to...
Recent pre-clinical studies confirm predictable, specific and statistically significant effects in multiple biological models.BELLEVUE, WA / ACCESSWIRE / February 15,...
STAR Foundation's Healing Retreats offers an in-depth approach to individual healing, using a blend of techniques from mainstream psychotherapy in...
Sound United’s iconic audio brands will benefit from Masimo’s expanded organizational resources to drive long-term innovation and development Masimo will...
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable...
Highlights for Fourth Quarter 2021: Revenues of $74.0 million; GAAP net income of $5.4 million and non-GAAP net income of...
Record Quarterly and Annual Results in First Year as Public Company Annual Total Revenue increased 48% year-over-year to $216.3 million...